Incidence and possible clinical significance of K-ras oncogene activation in adenocarcinoma of the human lung.
about
KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinibThe lysyl oxidase propeptide interacts with the receptor-type protein tyrosine phosphatase kappa and inhibits β-catenin transcriptional activity in lung cancer cellsWNT/TCF signaling through LEF1 and HOXB9 mediates lung adenocarcinoma metastasisSomatic mutations affect key pathways in lung adenocarcinomaThe role of RAS oncogene in survival of patients with lung cancer: a systematic review of the literature with meta-analysisPooled analysis of the prognostic and predictive effects of KRAS mutation status and KRAS mutation subtype in early-stage resected non-small-cell lung cancer in four trials of adjuvant chemotherapy.Novel insights into the molecular origins and treatment of lung cancerPulmonary adenocarcinoma: a renewed entity in 2011LIM and SH3 protein 1 promotes tumor proliferation and metastasis in lung carcinoma.Modeling cancer progression via pathway dependenciesParental bias of Ki-ras oncogenes detected in lung tumors from mouse hybrids.Molecular understanding of lung cancers-A review.Growth inhibitory effect of wild-type Kras2 gene on a colonic adenocarcinoma cell line.Epidermal growth factor receptor tyrosine kinase inhibitors for elderly patients with advanced non-small cell lung cancer.Loss of cytoplasmic CDK1 predicts poor survival in human lung cancer and confers chemotherapeutic resistanceC-erbB-2 expression and codon 12 K-ras mutations both predict shortened survival for patients with pulmonary adenocarcinomas.Signaling networks associated with AKT activation in non-small cell lung cancer (NSCLC): new insights on the role of phosphatydil-inositol-3 kinase.Ras in cancer and developmental diseasesConditional expression of the mutant Ki-rasG12C allele results in formation of benign lung adenomas: development of a novel mouse lung tumor model.Cooperation of c-raf-1 and c-myc protooncogenes in the neoplastic transformation of simian virus 40 large tumor antigen-immortalized human bronchial epithelial cells.Primary lung adenocarcinomas in children and adolescents treated for pediatric malignancies.Biomarkers in early-stage non-small-cell lung cancer: current concepts and future directions.Mind-mapping for lung cancer: towards a personalized therapeutics approachRole of proto-oncogene activation in carcinogenesis.Detection of ras gene mutations in human lung cancer: comparison of two screening assays based on the polymerase chain reaction.Interaction between smoking and asbestos in human lung adenocarcinoma: role of K-ras mutationsSuppression of lung adenocarcinoma progression by Nkx2-1RASSF1A promoter methylation and Kras2 mutations in non small cell lung cancerOncogenes and tumor-suppressor genes.Frequency and spectrum of mutations at codons 12 and 13 of the c-K-ras gene in human tumors.Activation of proto-oncogenes in human and mouse lung tumorsFrequency and spectrum of c-Ki-ras mutations in human sporadic colon carcinoma, carcinomas arising in ulcerative colitis, and pancreatic adenocarcinoma.Kinetics of O(6)-methyl-2'-deoxyguanosine repair by O(6)-alkylguanine DNA alkyltransferase within K-ras gene-derived DNA sequences.Lack of associations among cancer and albumin adducts, ras p21 oncoprotein levels, and CYP1A1, CYP2D6, NAT1, and NAT2 in a nested case-control study of lung cancer within the physicians' health study.Treatment of nonsmall cell lung cancer: overcoming the resistance to epidermal growth factor receptor inhibitors.Transition from squamous cell carcinoma to adenocarcinoma in adenosquamous carcinoma of the lungImmunohistochemical study of p53 in human lung carcinomas.Improved Classification of Lung Cancer Using Radial Basis Function Neural Network with Affine Transforms of Voss Representation.Therapeutic inhibition of TRF1 impairs the growth of p53-deficient K-RasG12V-induced lung cancer by induction of telomeric DNA damageGenetic analysis of lung tumours of non-smoking subjects: p53 gene mutations are constantly associated with loss of heterozygosity at the FHIT locus.
P2860
Q21563446-5F757167-0695-45B9-83EC-206A64746F8EQ24307235-C1BA49CB-5178-4837-95AB-4D62DCD74198Q24310644-53F4866C-B1E7-4E71-A06D-2147EEF1DE19Q24648102-C9732661-058B-4592-85E4-1A8B2369651FQ24650902-13F51C3B-535F-4FD1-98B7-6A3648FCFE49Q27313799-D1671F02-CED5-4E15-AB0F-0F687AC9E510Q28386773-BE5479C7-79B4-4771-8E44-5B371DC8DAC5Q28395348-64E56358-0F48-4084-9515-66BB4E41333EQ30008783-F976EA7A-3C46-4442-90BF-63EA7665D2DCQ33320177-2485E350-947E-49EB-9B42-BE11F0833199Q33611344-2E497B93-174F-4D09-B032-7931AA1F9BDEQ33628898-F32ABA01-1441-4322-A3B8-862E3973F566Q33787772-D2841D78-0911-40B6-AFCD-0685141515CDQ34001991-42D6737F-7675-46A5-AF4A-60D64DD3A211Q34009646-17E29045-F4E0-4C96-91F1-7FB25B1492F6Q34124421-205C4B54-99FE-4885-A3A0-8947F0A2593BQ34170007-1CC12FA1-2707-4CBB-920C-F97B6518992AQ34202697-B69EC529-8BE8-4E4F-8332-9C019FF5280CQ34313170-51CD788D-4683-4308-9868-9CED9FFD18B6Q34326650-E47DEC28-0069-468C-866B-EAE91278DBE3Q34570834-0656CC94-9813-453F-AE1C-E11258CF6639Q34623884-A367A9CB-DCB5-47BA-AC4D-32D4BB8B38EDQ34796086-3DED9FBA-9EF4-4FEF-9BB7-A6BEE881AFA4Q34844276-639E48C6-3CA7-40EE-AC49-6F7EA57095A2Q34844430-69707330-62B5-4C4B-8DC0-CA5643B02FE6Q34857705-56670363-0F9F-4ABD-8F74-F73D0B7E973DQ34939788-C77BD104-64CD-4DB4-A7D0-66B830DEB9C0Q34997482-9A295B04-36D1-4BF4-8094-963EC4EF47ABQ35034093-665CC12C-FBE5-46B3-A85B-93F5F6EDDBD9Q35034152-7EC78A81-DB00-46A3-8E11-5AE2C0293818Q35034174-FFF00730-5573-4E91-98D1-F601FD036D67Q35034184-F7D2F891-97BA-4208-A652-5755856200FCQ35540931-471AE3A1-1C66-45E5-8477-62E6E76EEC55Q35690757-57641960-5EF1-4B52-9B28-5121184AD68BQ35749960-15452A79-796A-4020-99C5-A4195DCFDA55Q35809964-CA6A9615-644F-44E4-900C-3FB053230CB8Q35832962-F629113D-3BC6-4D19-AE18-27CC0B3374ABQ35857400-44B0042E-45A9-4B02-9F03-FE171BC7C06EQ35904248-0E593790-4C54-424C-9E68-4654242A77C7Q36114860-8AE1E98D-5B2C-42D1-83D6-3A2FF1EAE466
P2860
Incidence and possible clinical significance of K-ras oncogene activation in adenocarcinoma of the human lung.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年学术文章
@wuu
1988年学术文章
@zh
1988年学术文章
@zh-cn
1988年学术文章
@zh-hans
1988年学术文章
@zh-my
1988年学术文章
@zh-sg
1988年學術文章
@yue
1988年學術文章
@zh-hant
name
Incidence and possible clinica ...... nocarcinoma of the human lung.
@en
Incidence and possible clinica ...... nocarcinoma of the human lung.
@nl
type
label
Incidence and possible clinica ...... nocarcinoma of the human lung.
@en
Incidence and possible clinica ...... nocarcinoma of the human lung.
@nl
prefLabel
Incidence and possible clinica ...... nocarcinoma of the human lung.
@en
Incidence and possible clinica ...... nocarcinoma of the human lung.
@nl
P2093
P1433
P1476
Incidence and possible clinica ...... enocarcinoma of the human lung
@en
P2093
Rodenhuis S
Wagenaar SS
van Bodegom PC
P304
P407
P577
1988-10-01T00:00:00Z